Chemotherapy and Targeted Therapy for Endocrine-Pretreated or Hormone Receptor– Negative Metastatic Breast Cancer - ASCO | Cliniscan
Cliniscan
Solutions
Tarifs
Ressources
Se connecter
Essayer gratuitement
Cliniscan
Retour aux recommandations
ASCO
2022
·
USA
·
Oncology
Chemotherapy and Targeted Therapy for Endocrine-Pretreated or Hormone Receptor– Negative Metastatic Breast Cancer
Document
Analyser ce document
